Biogen Compensation and benefits increased by 11.6% to $84.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $81.00M to $84.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase often reflects headcount growth or higher performance-based incentives, while a decrease may indicate efficiency initiatives or workforce reductions.
Includes all salaries, wages, bonuses, stock-based compensation, and employee benefit costs for the workforce. This is t...
Highly comparable across all sectors; usually found under 'Personnel' or 'Staffing' expenses.
compensation_and_benefits| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $54.10M | $55.70M | $67.60M | $55.70M | $63.60M | $75.60M | $71.50M | $62.20M | $72.80M | $70.60M | $72.70M | $81.00M | $74.90M | $75.30M | $84.00M |
| QoQ Change | — | +3.0% | +21.4% | -17.6% | +14.2% | +18.9% | -5.4% | -13.0% | +17.0% | -3.0% | +3.0% | +11.4% | -7.5% | +0.5% | +11.6% |
| YoY Change | — | — | — | +3.0% | +14.2% | +11.8% | +28.4% | -2.2% | -3.7% | -1.3% | +16.9% | +11.3% | +6.1% | +3.6% | +3.7% |